PRESS RELEASE published on 02/13/2026 at 15:36, 7 months 4 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group discloses a 5.03% interest in Beazley plc as of 12 February 2026 according to Form 8.3 filing Securities Form 8.3 Disclosure Vanguard Group Beazley Plc
PRESS RELEASE published on 02/13/2026 at 15:35, 7 months 4 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.51% stake in Schroders plc per Form 8.3, in compliance with the Takeover Code on 13-Feb-2026 Form 8.3 The Vanguard Group Takeover Code Schroders Plc Stake Disclosure
PRESS RELEASE published on 02/13/2026 at 15:34, 7 months 4 days ago Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses a 0.93% ownership in Life Science REIT plc through relevant securities. Purchase of 1p ordinary shares made at 0.43 GBP per unit The Vanguard Group Stock Purchase Ownership Disclosure Financial Disclosure Life Science REIT Plc
PRESS RELEASE published on 02/13/2026 at 15:34, 7 months 4 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses owning 5.23% of Picton Property Income Limited. Transactions include purchase of 6,648 securities at 0.88 GBP per unit Transactions The Vanguard Group, Inc. Stock Purchase Ownership Disclosure Picton Property Income Limited
BRIEF published on 02/12/2026 at 21:21, 7 months 5 days ago The Vanguard Group Discloses Position in JTC plc Takeover Code Securities Disclosure Shareholding Vanguard JTC Plc
BRIEF published on 02/12/2026 at 21:20, 7 months 5 days ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Limited Form 8.3 Disclosure Takeover Code Vanguard Bluefield Solar
BRIEF published on 02/12/2026 at 21:19, 7 months 5 days ago The Vanguard Group Discloses Position in Beazley plc Takeover Code Securities Disclosure Vanguard Group Shareholding Beazley Plc
BRIEF published on 02/12/2026 at 21:18, 7 months 5 days ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare
BRIEF published on 02/12/2026 at 21:18, 7 months 5 days ago Vanguard Group Discloses Position in Oxford Biomedica Form 8.3 Takeover Code Vanguard Group Stock Disclosure Oxford Biomedica
BRIEF published on 02/12/2026 at 21:16, 7 months 5 days ago The Vanguard Group Discloses Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group
Published on 09/18/2026 at 13:30, 37 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 7 hours 37 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 13 hours 12 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 13 hours 42 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/18/2026 at 13:52, 14 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 15 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/18/2026 at 13:50, 16 minutes ago Omio expands premium overnight travel options with Twiliner
Published on 09/18/2026 at 13:30, 36 minutes ago EQS-Adhoc: Sibanye Gold Limited: Notice to Bondholders
Published on 09/18/2026 at 13:30, 36 minutes ago EQS-Adhoc: Avemio AG: Preliminary Revenue and Earnings Figures for Fiscal Year 2025
Published on 09/17/2026 at 17:40, 20 hours 27 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 20 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 7 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
